MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0014737
GNH India Pharmaceuticals Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹26.12 Cr
▼ 36% YoY
Net profit · FY 2025
₹2.79 Cr
Net margin 10.7%
EBITDA · FY 2025
₹4.95 Cr
EBITDA margin 19%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹10.16 Cr
Issued & subscribed
Company age
8 yrs
Est. 2018
Employees · EPFO
32
Provident fund records
Directors on board
4
As per MCA filings
About GNH India Pharmaceuticals Limited
Data last updated:
GNH India Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2018PLC309277. Its GSTIN is 27AAHCG3150B1Z2 (Maharashtra).
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹10.16 Cr. It is led by directors including Piyush Ashok Gupta (Managing Director) and Jessica Piyush Gupta (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.12 Cr, a decline of 36% compared to the previous year. For the same year it recorded a net profit of ₹2.79 Cr (net margin 10.7%) and EBITDA of ₹4.95 Cr (EBITDA margin 19%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years.
The company has about 32 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: GNH India. Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending.
GNH India Pharmaceuticals Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0014737). For more details, the company can be reached via its website gnhindia.com.
Company details
CIN U51909MH2018PLC309277
Registration Number 309277
Incorporation Date 11 May 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-MH-19-0014737
Key People
Piyush Ashok Gupta Managing Director Jessica Piyush Gupta Whole-Time Director Savithav Nair Director Recognitions & Rankings of GNH India Pharmaceuticals
Contact details
GNH India Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is gnhindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit No. 14 15 16 17 Ground Floor Prabhadevi Industrial Estate, Enterprises Industrial Premises 408 Veer Sawarkar Road Prabhadevi, Mumbai, Maharashtra, India – 400025
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of GNH India Pharmaceuticals Limited, buy the company report.
Comprehensive company report
GNH India Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
GNH India Pharmaceuticals operates one associated brand: GNH India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Global distributor of pharmaceuticals, focusing on orphan drugs and supply chain services. | gnhindia.com |
Business activity
The main business activity of GNH India Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of GNH India Pharmaceuticals Limited, buy the company report.
Financials of GNH India Pharmaceuticals Limited
FY 2025 filings availableGNH India Pharmaceuticals Limited reported revenue of ₹26.12 Cr (down 36% YoY) for FY 2025.
Revenue · FY 2025
₹26.12 Cr ▼ 36%
Net profit · FY 2025
₹2.79 Cr margin 10.7%
EBITDA · FY 2025
₹4.95 Cr margin 19%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 36%
3 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 41%
3 years · compounded
▼ 11%
Revenue fell 36% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹26.12 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.95 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.79 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19% | ||||
| Net Profit Margin | 10.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of GNH India Pharmaceuticals Limited, buy the company report.
Board of directors of GNH India Pharmaceuticals Limited
GNH India Pharmaceuticals has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Piyush Ashok Gupta | Managing Director | 11 May 2018 | 8 Years 6 Months | Current |
| Jessica Piyush Gupta | Whole-Time Director | 11 May 2018 | 8 Years 6 Months | Current |
| Savithav Nair Also directs: Midland Sports and Wellness Private Limited | Director | 17 Aug 2024 | 2 Years 2 Months | Current |
| Dharmesh Pravin Kharwar Also directs: Zodiac-Jrd-Mkj Limited, Vem Plastic Molding Private Limited, NGB Laboratories Private Limited and 1 more | Director | 13 Apr 2026 | 0 Years 6 Months | Current |
Peer comparison
GNH India Pharmaceuticals Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cibeles Pharmaceuticals Private Limited | ₹27.15 Cr (FY 2025) | 48.0% | Mumbai, Maharashtra, India | |||
| GNH India Pharmaceuticals Limitedthis company | ₹26.12 Cr (FY 2025) | ₹2.79 Cr | 10.7% | -36.0% | 32 | Mumbai, Maharashtra, India |
| Senses Pharmaceuticals Private Limited | ₹26.08 Cr (FY 2025) | 0.0% | Bangalore, Karnataka, India | |||
| Asle Pharmaceuticals Private Limited | ₹25.9 Cr (FY 2025) | 7.0% | Jaipur, Rajasthan, India | |||
| Darwin Platform Pharmaceuticals Limited | ₹25.84 Cr (FY 2024) | 0.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of GNH India Pharmaceuticals Limited, buy the company report.
Auditor
GNH India Pharmaceuticals Limited is audited by Desai Agrawal & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Desai Agrawal & Associates | FY 2023 | 143534W |
Shareholding
The shareholding of GNH India Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of GNH India Pharmaceuticals Limited, buy the company report.
Legal cases
GNH India Pharmaceuticals Limited has 3 court cases on record: 3 filed by GNH India Pharmaceuticals. All cases are pending.
Total cases
3
Filed by the company
3
Pending
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 3 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (CHAMBER SUMMONS) | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (SUMMARY CIVIL SUIT) | Filed by the company against an individual | Pending |
To see the full case history of GNH India Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
GNH India Pharmaceuticals Limited has 3 MSME Form 1 returns on record between 2021 and 2023, listing 3 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Trends Pharma Pvt Ltd |
To see the full MSME payment records of GNH India Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
GNH India Pharmaceuticals Limited has a workforce of 32 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
32
Active EPFO establishments
1
Employee growth
23.1%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 32 |
| FY 2025-26 | |
| FY 2024-25 |
To see the full employee and EPFO history of GNH India Pharmaceuticals Limited, buy the company report.
GST
GNH India Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCG3150B1Z2 | Maharashtra | Active | 14 May 2019 |
To see the full GST registrations and return filing status of GNH India Pharmaceuticals Limited, buy the company report.
Recent activity
GNH India Pharmaceuticals Limited has 11 board changes on record since 2018: 4 appointments and 7 cessations. The latest: Dharmesh Pravin Kharwar was appointed as Director on 13 Apr 2026.
Appointed
Dharmesh Pravin Kharwar was appointed as Director.
AGM
Gnh India Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Gnh India Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Harshal Suresh Parmar ceased to be Additional Director.
Ceased
Savithav Nair ceased to be Director Appointed In Casual Vacancy.
Appointed
Savithav Nair was appointed as Director.
Ceased
Jigar Rakesh Shah ceased to be Director.
Ceased
Utsav Milan Shah ceased to be Director.
Ceased
Shwetha Sudarshan Akkela ceased to be Director.
Ceased
Jessica Piyush Gupta ceased to be Director.
Ceased
Piyush Ashok Gupta ceased to be Director.
Appointed
Jessica Piyush Gupta was appointed as Whole-Time Director.
2 earlier events are in the company report.
Frequently asked questions
GNH India Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 May 2018 (8+ years old) and is registered under CIN U51909MH2018PLC309277.
GNH India Pharmaceuticals has 4 current directors:
- Piyush Ashok Gupta - Managing Director
- Jessica Piyush Gupta - Whole-Time Director
- Savithav Nair - Director
- Dharmesh Pravin Kharwar - Director
The latest financial statements of GNH India Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of GNH India Pharmaceuticals is 27AAHCG3150B1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of GNH India Pharmaceuticals is U51909MH2018PLC309277. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
GNH India Pharmaceuticals has 3 court cases on record: 3 filed by the company. 3 are pending.
GNH India Pharmaceuticals was incorporated on 11 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of GNH India Pharmaceuticals by revenue are Cibeles Pharmaceuticals Private Limited, Senses Pharmaceuticals Private Limited, Asle Pharmaceuticals Private Limited, Darwin Platform Pharmaceuticals Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Dharmesh Pravin Kharwar was appointed as Director on 13 Apr 2026. Harshal Suresh Parmar ceased to be Additional Director on 29 Sep 2024. Savithav Nair ceased to be Director Appointed In Casual Vacancy on 29 Sep 2024. GNH India Pharmaceuticals has 11 board changes on record in total.
Yes, GNH India Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0014737).
GNH India Pharmaceuticals has 3 MSME Form 1 returns on record between 2021 and 2023, listing 3 overdue payments to 2 micro and small suppliers. The latest return was filed on 29 Aug 2023.
GNH India Pharmaceuticals can be reached through the website gnhindia.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages